Alfarsi LH, El Ansari R, Craze ML, Mohammed OJ, et al. SLC1A5 co-expression with TALDO1 associates with endocrine therapy failure in estrogen receptor-positive breast cancer. Breast Cancer Res Treat 2021 Jul 19. pii: 10.1007/s10549-021-06298.
PMID: 34282517